Avantor Featured Articles

  1. Performance Of Protein A Resins For Different mAbs 7/20/2023

    Review a Protein A resin solution assisting biotech companies who are working with and removing impurities from a wide variety of antibodies.

  2. Solving Cost And Supply Challenges In Biopharma Downstream Processing 7/20/2023

    In response to the growing demand for monoclonal antibodies, researchers are looking at different areas of the downstream process where they can improve efficiency and scalability.

  3. De-risks Your Monoclonal Antibody Scale-Up Process 7/20/2023

    Improve your mAb production by adopting a technology platform approach using a fluid handling system that can transition from development to your final production volume.

  4. The Case For Early Use Of cGMP Raw Materials 7/14/2023

    Using cGMP grade reagents earlier makes for a seamless transition while maintaining quality and viability.

  5. Downstream Process Intensification: Enhanced mAb Purification 5/13/2021

    Learn more about an integrated monoclonal antibody (mAb) downstream purification process that enables significant throughput improvement while removing critical impurities.

  6. Achieve Downstream Process Improvements Through Buffer Management 3/23/2021

    Understanding the alternative buffer management and preparation strategies available can ensure you have the tools and resources to remain competitive in today’s growing bioprocessing industry.

  7. Bioprocess Sampling Case Study 9/23/2020

    A GMP-compliant, novel process sampling solution for taking multiple conical tube samples at varying time points results in immediate process efficiency and sterility assurance.

  8. Global Single-Use Supply Chains: Managing Risk, Minimizing Complexity 9/23/2020

    Biopharma manufacturers can benefit by adopting a global single-use supply chain strategy early in the drug development life cycle and carefully evaluating their single-use equipment and materials suppliers.